Make your tax-deductible contributions by Dec 31 ⏰

Daffy

Carcinoid Cancer Foundation, Inc.

Carcinoid Cancer Foundation, Inc.

Mount Kisco, NY 10549
Tax ID13-6277875

Want to make a donation using Daffy?

Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.

Payment method

Frequency

Amount

$USD
Daffy covers all ACH transaction fees so 100% of your donation goes to your favorite charities.

Do you work for Carcinoid Cancer Foundation, Inc.? Learn more here.

By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.

About this organization

Revenue

$557,464

Expenses

$480,559

Mission

The mission of the Carcinoid Cancer Foundation is to increase awareness and educate the general public and healthcare professionals regarding carcinoid and related neuroendocrine tumors (NETs), to support NET cancer patients and their families, and to serve as patient advocates.

About

Provides information and education for medical professionals, patients, caregivers, and the general public; provides e-mail and telephone support; works to improve access to accurate and up-to-date information. Digital outreach nationally and internationally through CCF's website, e-newsletter, blog and social media channels, including Facebook, YouTube and Twitter, reaches over 400,000 people annually in more than 150 countries.

Interesting data from their 2019 990 filing

The non-profit's aim, as indicated in the filing, is “Education of medical professionals and the general public; advocacy and support of patients and families of patients; support research in the area of carcinoid and neuroendocrine tumors.”.

When referring to its functions, they were specified as: “Education of medical professionals and the general public; advocacy and support of patients and families of patients; support research in the area of carcinoid and neuroendocrine tumors.”.

  • The non-profit has reported their operating state as NY, as required by law.
  • As stated in the filing, the non-profit's address in 2019 was 832 SO MILWAUKEE STREET, DENVER, CO, 80209.
  • The non-profit's form reports a total of 3 employees as of 2019.
  • Does not operate a hospital.
  • Does not operate a school.
  • Does not collect art.
  • Does not provide credit counseling.
  • Does not have foreign activities.
  • Is not a donor-advised fund.
  • Is not a private foundation.
  • Expenses are between $500,000 and $1,000,000+.
  • Revenue is between $500,000 and $1,000,000+.
  • Revenue less expenses is $76,905.
  • The remuneration of the CEO of the organization is not determined through an impartial review and approval process.
  • The organization has 6 independent voting members.
  • The organization was formed in 1968.
  • The organization has a written policy that addresses conflicts of interest.
  • The organization is required to file Schedule B.
  • The organization is required to file Schedule O.
  • The organization pays $215,388 in salary, compensation, and benefits to its employees.
  • The organization pays $18,785 in fundraising expenses.
  • The organization has minutes of its meetings.
  • The organization has a written whistleblower policy.